Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
申请人:Moinet Gerard
公开号:US20080108619A1
公开(公告)日:2008-05-08
The invention relates to the compounds of general formula (I):
in which R1, R2, R3, R4, R5 and R6 are as defined in Claim
1.
These compounds can be used in the treatment of pathological conditions associated with the insulin-resistance syndrome.
US7452883B2
申请人:——
公开号:US7452883B2
公开(公告)日:2008-11-18
US7767676B2
申请人:——
公开号:US7767676B2
公开(公告)日:2010-08-03
[EN] COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SECRETION STIMULATORS<br/>[FR] COMBINAISON DE DERIVES DE TRIAZINE ET DE STIMULATEURS DE SECRETION D'INSULINE
申请人:MERCK PATENT GMBH
公开号:WO2007079914A2
公开(公告)日:2007-07-19
[EN] The present patent application relates to novel combinations of a triazine derivative and of an insulin secretion stimulator. [FR] La présente invention concerne de nouvelles combinaisons d'un dérivé de triazine et d'un stimulateur de sécrétion d'insuline.
Hypoglycemic Agents. IV.<sup>1—3</sup> N<sup>1</sup>,N<sup>5</sup>-Alkyl- and Aralkylbiguanides
作者:Seymour L. Shapiro、Vincent A. Parrino、Louis Freedman